Last updated: April 25, 2026
Bremelanotide Acetate: Who supplies the active ingredient (API) and key intermediates?
No complete, reliable supplier list for bremelanotide acetate (API and/or key intermediates) can be produced from the information available in this workspace.
Which suppliers can be cited for bremelanotide acetate?
None can be listed with sufficient evidentiary support.
What is the evidence set normally used to build a supplier map?
A supplier map for an opioid-like peptide/peptide-analog API such as bremelanotide acetate is typically grounded in one or more of the following categories of primary records:
- Regulatory filings (for example, NDC-linked product labels, Drug Master File references, or application-specific chemistry/manufacturing controls)
- Patent specifications that name manufacturing sites, contract manufacturers, or reagent/intermediate sources
- Commercial supply disclosures (catalog pages and material specifications tied to CAS and salt form)
- Quality documentation that ties an API lot to a named manufacturer (CoA header and testing report)
No such evidence is present here, so producing a “suppliers” list would require fabrication.
Key Takeaways
- A complete, accurate, cite-able supplier list for bremelanotide acetate cannot be generated from the available data in this workspace.
- Publishing supplier names without regulatory or patent-grade evidence would not meet a high-stakes drug supply diligence standard.
FAQs
1) Can you list bremelanotide acetate API suppliers now?
No supplier list can be produced with sufficient evidentiary support.
2) Are there common contract manufacturers for peptide APIs that likely make bremelanotide?
No named suppliers can be stated without citeable records tying them to bremelanotide acetate specifically.
3) Does the “acetate” salt change supplier availability versus the free base?
Salt form can affect which suppliers can supply the exact drug substance, but no verified mapping can be provided here.
4) Can patent assignees be treated as suppliers?
Assignees are not suppliers by definition; only filings that explicitly identify manufacturing or sourcing parties can support a supplier attribution.
5) Can supplier names be inferred from company websites or catalogs?
Only if the catalogs specify bremelanotide acetate by identity and salt form and can be matched to auditable documentation. No such sourced materials are present here.
References
[1]
